Important generic biotech drugs Information
Generic Biotech Drugs
March 1, 2010 -- HASH(0x2a966aef70) Accelerate Competition to Lower Costs, Increase Access WASHINGTON -- The Pharmaceutical Care...
February 24, 2010 -- HASH(0x1f07a20) Biotech Products May Soon Face New Competition Under Healthcare Reform NEW YORK -- Makovsky +...
January 22, 2010 --
Biotechnology major Biocon, which tied up with Pennsylvania-based Mylan last year to develop monoclonals and biogenerics for the Western...
January 16, 2010 --
Drug companies threatening to oppose overhaul WASHINGTON -- The drug industry is threatening to end its support for President Barack Obama's...
November 16, 2009 -- NEW YORK -- For the last year, the possibility of a regulatory approval pathway for biosimilars--cheaper knockoffs of biotech drugs--has advanced...
November 13, 2009 -- M2 PRESSWIRE-13 November 2009-Bharat Book Bureau: Global Pharmaceutical Market Forecast(C)1994-2009 M2 COMMUNICATIONS RDATE:13112009 ...
November 10, 2009 --
The race to enter the lucrative $60 billion US biologics market is getting tougher by the day for domestic biopharma companies.
The US...
October 14, 2009 -- Byline: Linda A. Johnson Associated Press TRENTON, N.J. u Johnson & Johnson on Tuesday reported a meager 1 percent increase in third-quarter...
October 14, 2009 --
TRENTON, N.J. - Band-Aid maker Johnson & Johnson is feeling the pain as consumers worldwide buy more generic health products - whether it's...
September 28, 2009 -- LifeMasters to Diversify After It Emerges From Bankruptcy; AMDL Renames, Starts Subsidiary HEALTHCARE Watson Pharmaceuticals Inc., a drug maker...